Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07727135 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rapid or Ultra-rapid Diagnosis of Myocardial Infarction Using High-Sensitivity Cardiac Troponin on Hospital Presentation

Study acronym: DanRUSH
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 2 changed
See other at-risk trials from Herlev and Gentofte Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modifiedv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
People with chest pain are often tested for a heart attack using a blood test called high-sensitivity cardiac troponin (hs-cTn). Traditionally, this blood test is repeated 3 hours after the first sample. Newer guidelines recommend repeating the test after 1 hour instead, which may allow patients to receive a diagnosis and leave the hospital sooner. The purpose of the DanRUSH trial is to compare these two strategies: repeating the blood test after 1 hour versus after 3 hours in adults with suspected acute coronary syndrome. The study will evaluate whether the 1-hour strategy is as safe as the 3-hour strategy while reducing the length of hospital stay. DanRUSH is a nationwide, pragmatic, cluster-randomized trial conducted in emergency- and cardiology departments across Denmark. The results will help determine the best timing for blood testing in patients with suspected heart attack and improve future care for these patients.
Trial Details
NCT Number NCT07727135
Lead Sponsor Herlev and Gentofte Hospital
Collaborators: Bispeberg and Frederiksberg Hospital, Hvidovre and Amager Hospital, North Zealand (Hillerød) Hospital, Nykøbing Falster Sygehus, Gødstrup Hospital, Regionshospitalet Viborg, Skive, Odense Universitetshospital, Esbjerg sygehus, Aalborg University Hospital
Conditions
(from sponsor)		 Coronary Syndrome, Acute, Myocardial Infarction, Coronary Artery Disease, Cardiovascular Diseases, Cardiovascular Disease Acute
Related terms Acute Coronary Syndrome, Angina, Unstable, Cardiovascular Diseases, Coronary Artery Disease, Myocardial Infarction
Enrollment 28,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov